BIOTRICITY INC.

REDWOOD CITY, CA · Founded 2012 · Medtech · Public

Bioflux-AI, a real-time cardiac monitoring and stroke risk prediction system combining a wearable mobile cardiac telemetry device with AI algorithms for chronic kidney disease patients

Claim this profile

Follows are private to you and power your alerts

Updated · biotricity.com

Sector
Medtech
Headquarters
REDWOOD CITY, CA
Founded
2012
Latest Form D
$1M, Apr 2024
Total capital
$10.3M
Federal grants
$240K
1 award · 2022
Rank in peer group#267 of 542
Private capital raised
$10M
5 Form D · last Apr 2024
31 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
0
3 pending

Capital timeline

20162018202020222024FEDERAL ↑EQUITY ↓Cumulative $10.3M$240K2nd Form D$1.2M3rd Form D$6M4th Form D$1.3M5th Form D$1M
20162018202020222024FEDERAL ↑EQUITY ↓Cumulative $10.3M$240K3rd Form D$6M4th Form D$1.3M

Latest events

  • Private capital raisedForm D · SEC · 5th filing$1M
  • Federal grantHealth and Human S · Phase I · AI-enabled Stroke Prediction in Patients with Chronic Kidney Disease$240K
  • Private capital raisedForm D · SEC · 4th filing$1.3M
  • Private capital raisedForm D · SEC · 3rd filing$6M
  • Private capital raisedForm D · SEC · 2nd filing$1.2M
  • Private capital raisedForm D · SEC · 1st filing$525K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grants#267 · top 49%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Waqaas Al-SiddiqResearcherExecutive Officer, DirectorLinked by $240K in grants as PI
  • Chester A. WhiteDirectorNamed in SEC Form D filings
  • David A. RosaDirectorNamed in SEC Form D filings
  • John AyanoglouExecutive OfficerNamed in SEC Form D filings
  • Norman BettsDirectorNamed in SEC Form D filings
  • Norman M. Betts, M.D.DirectorNamed in SEC Form D filings
Show all 9 people
  • Patricia KennedyDirectorNamed in SEC Form D filings
  • Ronald A. McClurgDirectorNamed in SEC Form D filings
  • Steve SalmonDirectorNamed in SEC Form D filings

What it has protected

USPTO · 0 granted of 3
  • PendingSmart Patch For Monitoring Health MetricsUSPTOApplication 19048220
  • PendingMulti-sensor Wearable PatchUSPTOApplication 18274921
  • PendingReconfigurable Device For Monitoring Health MetricsUSPTOApplication 18033251
  • 3Oe Scientific, LLCSimilar federal contract value in Medtech · null in contracts
  • Sana Health, Inc.Similar federal contract value in Medtech · null in contracts
  • Dragon Vascular, Inc.Similar federal contract value in Medtech · null in contracts
  • Eyas Medical Imaging, Inc.Similar federal contract value in Medtech · null in contracts
  • Gen9, Inc.Similar federal contract value in Medtech · null in contracts
  • STRATEOS SUB, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .